{"title":"2型糖尿病心血管和肾脏预后的改善:血糖控制的作用，而不是药物的作用","authors":"U. Kabadi","doi":"10.15406/JDMDC.2021.08.00225","DOIUrl":null,"url":null,"abstract":"because of lack of administration of equivalent daily doses in drug naive subjects. Moreover, the data regarding impact of new drugs on cardiovascular and renal outcomes is overstated as these trials demonstrate no additional improvement beyond that achieved by improvement in glycemic control. Finally","PeriodicalId":92240,"journal":{"name":"Journal of diabetes, metabolic disorders & control","volume":"27 1","pages":"76-77"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Improvement in cardiovascular and renal outcomes in type 2 diabetes: effect of glycemic control, not drugs\",\"authors\":\"U. Kabadi\",\"doi\":\"10.15406/JDMDC.2021.08.00225\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"because of lack of administration of equivalent daily doses in drug naive subjects. Moreover, the data regarding impact of new drugs on cardiovascular and renal outcomes is overstated as these trials demonstrate no additional improvement beyond that achieved by improvement in glycemic control. Finally\",\"PeriodicalId\":92240,\"journal\":{\"name\":\"Journal of diabetes, metabolic disorders & control\",\"volume\":\"27 1\",\"pages\":\"76-77\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of diabetes, metabolic disorders & control\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/JDMDC.2021.08.00225\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of diabetes, metabolic disorders & control","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/JDMDC.2021.08.00225","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Improvement in cardiovascular and renal outcomes in type 2 diabetes: effect of glycemic control, not drugs
because of lack of administration of equivalent daily doses in drug naive subjects. Moreover, the data regarding impact of new drugs on cardiovascular and renal outcomes is overstated as these trials demonstrate no additional improvement beyond that achieved by improvement in glycemic control. Finally
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
